Editorial

Volume: 5 | Issue: 2 | Published: Nov 05, 2022 | Pages: 059 - 060 | DOI: 10.24911/JBCGenetics/183-1653668216

Vosoritide: a drug providing a promising avenue for the treatment of short stature in children with achondroplasia

Authors: Amsal Qureshi , Areesha Moiz Alvi

Abstract

Not available

Keywords: Achondroplasia, Vosoritide, FGFR3, children, CNP

Open access Creative Commons License

Pubmed Style

Amsal Qureshi, Areesha Moiz Alvi. Vosoritide: a drug providing a promising avenue for the treatment of short stature in children with achondroplasia. JBC Genetics. 2022; 05 (November 2022): 059-060. doi:10.24911/JBCGenetics/183-1653668216

Publication History

Received: May 27, 2022

Revised: July 09, 2022

Accepted: October 16, 2022

Published: November 05, 2022

Authors

Amsal Qureshi

Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan

Areesha Moiz Alvi

Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.